Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for anesthesia in off-pump coronary artery bypass graft surgery
ChiCTR2000030409Phase 4Recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in coronary arteriosclerosis (2 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoints: Hemodynamic changes, Application of vasoactive drugs and 4 more. Started Mar 2020; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2000030409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030409.